Bowel habit subtypes and temporal patterns in irritable bowel syndrome: Systematic review

American Journal of Gastroenterology

Volumn 100, Issue 5, 2005, Pages 1174-1184

  Guilera, Magda ^a   Balboa, Agustin ^b   Mearin, Fermin ^b  

^a Health Outcomes Research Europe   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE COURSE; EMBASE; EUROPE; EVALUATION; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INTESTINE FUNCTION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SELF REPORT; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; UNITED STATES; DEFECATION; INTESTINE; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ABDOMINAL PAIN; CONSTIPATION; DEFECATION; DIARRHEA; FOLLOW-UP STUDIES; HUMANS; INTESTINES; IRRITABLE BOWEL SYNDROME; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 19144366647     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40674.x     Document Type: Review

References (46)

1. Camilleri M, Heading RC, Thompson WG. Consensus report: Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther 2002;16:1407-30.
2. Talley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of colonie symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-34.
3. Delvaux M. Functional bowel disorders and irritable bowel syndrome in Europe. Aliment Pharmacol Ther 2003;18(Suppl3):75-9.
4. El-Serag HB. Impact of irritable bowel syndrome: Prevalence and effect on health-related quality of life. Rev Gastroenterol Disord 2003;3(Suppl 2):S3-11.
5. Camilleri M, Ford MJ. Functional gastrointestinal disease and the autonomic nervous system: A way ahead? Gastroenterology 1995;106:1114-8.
6. Drossman DA. Review article: An integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther 1999;13(Suppl2):3-14.
7. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. BMJ 1978; 2:653-4.
8. Thompson WG, Dotevall G, Drossman DA, et al. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterol Int 1989;2:92-5.
9. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl II):43-7.
10. Drossman DA, Corazziari E, Talley NJ, et al. Rome II. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: A multinational consensus, 2nd Ed. McLean, VA: Degnon Associates, 2000.
11. Chey WD, Olden K, Carter E, et al. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 2002;97:2803-11.
12. Saito YA, Locke GR, Talley NJ, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000;95:2679-81.
13. Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: Comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155-61.
14. Heaton KW, O'Donnell LJD, Braddon FEM, et al. Symptoms of irritable bowel syndrome in a British urban community: Consulters and non-consulters. Gastroenterology 1992;102:1962-7.
15. Talley NJ, Zinsmeister AR, Melton III LJ. Irritable bowel syndrome in a community: Symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995;142:76-83.
16. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
17. Masud MA, Hasan M, Khan K. Irritable bowel syndrome in a rural community in Bangladesh: Prevalence, symptoms pattern, and health care seeking behavior. Am J Gastroenterol 2001;96:1547-52.
18. Bommelaer G, Dorval E, Denis P, et al. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol 2002;26: 1118-23.
19. Kwan AC, Hu WH, Chan YK, et al. Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 2002;17:1180-6.
20. Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17:643-50.
21. Mearin F, Balboa A, Badia X, et al. Irritable bowel syndrome subtypes according to bowel habit: Revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003;15:165-72.
22. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology 1980; 79:283-8.
23. Bommelaer G, Rouch M, Dapoigny M, et al. Épidémiologie des troubles fonctionnels intestinaux dans une population apparemment saine. Gastroenterol Clin Biol 1986;10:7-12.
24. Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily-recorded symptoms in two outpatient samples. Scand J Gastroenterol 1999;34:993-1000.
25. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defecation in the irritable bowel syndrome. Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998;10:415-21.
26. Mearin F, Baró E, Roset M, et al. Clinical patterns over time in irritable bowel syndrome: Symptom instability and severity variability. Am J Gastroenterol 2004;99:113-21.
27. Harvey RJ, Brown AM, Mauad EC. Prognosis in the irritable bowel syndrome: A 5-year prospective study. Lancet 1987;1:963-5.
28. Danquechin DE, Delvaux M, Allemand H, et al. Profil et évolution du syndrome de l'intestin irritable. Gastroenterol Clin Biol 1994;18:145-50.
29. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: Long term prognosis and the physician-patient interaction. Ann Intern Med 1995;122:107-12.
30. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94:1320-6.
31. Schmulson M, Lee OY, Chang L, et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999;94:2929-35.
32. Lee OY, Fitzgerald Z, Naliboff B, et al. Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome. Aliment Pharmacol Ther 1999;13:1631-8.
33. Simren M, Abrahamsson H, Svedlund J, et al. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: The impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545-52.
34. Heaton KW, Ghosh S, Braddon FEM. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991; 32:73-9.
35. Stevens JA, Wan CK, Blanchard EB. The short natural history of irritable bowel syndrome: A time-series analysis. Behav Res Ther 1997;35:319-26.
36. Hahn B, Watson M, Yan S, et al. Irritable bowel syndrome symptom patterns. Frequency, duration and severity. Dig Dis Sci 1998;43:2715-8.
37. Jones R. Likely impacts of recruitment site and methodology on characteristics of enrolled patient population: Irritable bowel syndrome clinical trial design. Am J Med 1999;107:85S-90S.
38. Mearin F, Roset M, Badía X, et al. Splitting irritable bowel syndrome: From original Rome to Rome II criteria. Am J Gastroenterol 2004;99:122-30.
39. Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial. Lancet 2000;355:1035-40.
40. Stacher G, Weber U, Stacher-Janotta G, et al. Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial. Br J Clin Pharmacol 2000; 49:429-36.
41. Mueller-Lissner S, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT4 partial agonist, relieves key symptoms of irritable bowel syndrome. Gastroenterology 2000;118:A175.
42. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(Suppl 2):II69-77.
43. Sandler RS, Drossman DA, Nathan HP, et al. Symptom complaints and health care seeking behavior in subjects. Gastroenterology 1984;87:314-8.
44. Thompson WG, Heaton KW, Smyth GT, et al. Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral. Gut 2000;46:78-82.
45. Simrén M, Abrahamsson H, Svedlund J, et al. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: The impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545-52.
46. Gomborone JE, Dewnap PA, Libby GW, et al. Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut 1993;34:1230-3.